| Product Code: ETC9945242 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Genetic Disease Diagnostic Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Genetic Disease Diagnostic Market - Industry Life Cycle |
3.4 United Kingdom (UK) Genetic Disease Diagnostic Market - Porter's Five Forces |
3.5 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Kingdom (UK) Genetic Disease Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic diseases in the UK population |
4.2.2 Technological advancements in genetic testing and diagnostics |
4.2.3 Growing awareness and acceptance of genetic testing for early disease detection |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for genetic testing |
4.3.2 High costs associated with genetic disease diagnostics |
4.3.3 Limited accessibility to genetic testing services in certain regions of the UK |
5 United Kingdom (UK) Genetic Disease Diagnostic Market Trends |
6 United Kingdom (UK) Genetic Disease Diagnostic Market, By Types |
6.1 United Kingdom (UK) Genetic Disease Diagnostic Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Prenatal Diagnosis, 2021- 2031F |
6.1.4 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 United Kingdom (UK) Genetic Disease Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Inherited Disorder Testing, 2021- 2031F |
6.2.3 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Pharmacogenetic Testing (Pgx), 2021- 2031F |
6.2.4 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Human Leukocyte Antigen (Hla) Testing, 2021- 2031F |
6.2.5 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Oncology Testing, 2021- 2031F |
7 United Kingdom (UK) Genetic Disease Diagnostic Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Genetic Disease Diagnostic Market Export to Major Countries |
7.2 United Kingdom (UK) Genetic Disease Diagnostic Market Imports from Major Countries |
8 United Kingdom (UK) Genetic Disease Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of genetic testing services by healthcare providers |
8.2 Number of genetic testing labs and facilities in the UK |
8.3 Percentage of the UK population with access to genetic disease diagnostic services |
9 United Kingdom (UK) Genetic Disease Diagnostic Market - Opportunity Assessment |
9.1 United Kingdom (UK) Genetic Disease Diagnostic Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United Kingdom (UK) Genetic Disease Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Kingdom (UK) Genetic Disease Diagnostic Market - Competitive Landscape |
10.1 United Kingdom (UK) Genetic Disease Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Genetic Disease Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here